Pharmacy alerts
-
ACE-inhibitors: the distinction between bradykinin- and histamine-mediated angioedema
The MHRA has published a drug safety update on ACE-inhibitors and the distinction between bradykinin- and histamine-mediated angioedema.
-
Orbit Pharma Limited, cyclizine lactate 50mg/ml solution for injection recall
The MHRA has published a class 3 medicines recall for cyclizine lactate 50mg/ml solution for injection.
-
Cadila Pharmaceuticals Limited, mirtazapine 30mg tablets defect
The MHRA has published a class 4 medicines defect notification for mirtazapine 30mg tablets.
-
Teva UK Ltd, Ponlimsi (Denosumab) 60mg solution for injection in pre-filled syringe defect
The MHRA has published a Class 4 medicines defect notification for Ponlimsi (denosumab) 60mg solution for injection in pre-filled syringe.
-
Ebola outbreak, UKHSA issues urgent public health message
The NHS and independent healthcare providers are reminded of actions in detection and management of suspected cases of Ebola disease.
-
Becton Dickinson UK Ltd, ChloraPrep 2% 1mL and ChloraPrep Frepp 2% 1.5mL applicators recall
The MHRA has published a Class 2 medicines recall for ChloraPrep 2% 1mL and ChloraPrep Frepp 2% 1.5mL applicators.